Dementia, Multiple Sclerosis, Stroke & Babies’ Brain Bleeds Among Neuro Conditions Receiving New Research Funding
The Neurological Foundation of New Zealand has awarded $3.4 million in research grants to support 25 projects focused on conditions like stroke, dementia, and multiple sclerosis. The funding comes amid a reported decline in government medical research support, highlighting the growing role of private donors in neuroscience.
Why it matters
Increased private funding for neurological research is critical as the prevalence of brain-related conditions rises globally, potentially leading to new treatments for aging populations.
News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | /" style="white-space: nowrap">Search
New Zealand’s neuroscience community has just received a $3.4 million injection from the Neurological Foundation for research into a broad range of neurological conditions.
The Foundation’s CEO, Rich Easton, says, “This investment will benefit a wide range of New Zealanders, from the tiniest babies to our precious senior citizens. We are excited to back brilliant researchers as they seek answers to some of the most urgent questions in healthcare.”
The Foundation received 84 applications – the most ever submitted in a grants round – and funded 25. The conditions being researched include dementia, stroke, multiple sclerosis, Huntington’s disease, chronic traumatic encephalopathy (CTE), premature babies’ brain bleeds, pain & cognition, and post-surgery delirium.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in